Cryptocurrencies and blockchain are making their way into almost everything we do. And that means massive investment potential for investors. More
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
What did the stock market do today? Investors were watching big moves in reopening plays, cannabis names and NFT stocks. More
Capital Raises and Clinical Programs Prove the Progress of Citius Pharmaceuticals
It's a great time to hold CTXR stock as the company's CEO shares his vision of significant corporate developments and clinical progress. More
FDA Approval Sheds New Light on Second Sight Medical Products
You won't believe your eyes when you see the ultra-bullish price action in EYES stock, along with the game-changing regulatory announcement. More
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 220 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. More
DYAI Stock: Why Covid-19 Vaccine Play Dyadic Is Shooting Higher Today
Dyadic International is surging today after it announced a Covid-19 vaccine partnership with Medytox, but that isn't the only bullish news for this small cap biotech stock. More
Step Into the Drone Age with a Stake in AgEagle Aerial Systems
A short seller recently issued a harsh report on UAVS stock. Now that the share price has declined, it could be time to take a long position. More
